About ATMA CENA
We're dedicated to improving mental healthcare with evidence-based psychedelic therapy. Our innovative approach blends the latest research with a client-focused touch, ensuring you receive top-quality, personalized care.
Our vision
Empowering every individual to enrich their lives through accessible psychedelic medicine.
Our values
Accessibility, Safety, Innovation, Collaboration, Integrity.
Our goal
To establish a service hub in every major population center across Canada, ensuring accessible, equitable psychedelic healthcare for all Canadians.
Our mission
To build capability and capacity for wellbeing through open collaboration with partners in public, private and not-for-profit organizations to provide safe psychedelic care.
Why choose ATMA CENA?
Evidence-based treatments
Our therapy programs are grounded in the latest scientific evidence, providing safe and effective care that you can trust.
Accessible and affordable
We ensure our services can integrate with existing healthcare policies and regulations making these innovative therapies accessible and affordable for all.
Personalized care
Our client-centric approach prioritizes your well-being, with effective treatments that minimize stress and maximize results. We empower you to actively participate in your care.
Interdisciplinary expertise
Our team of psychiatrists, physicians, nurse practitioners, nurses, and therapists work collaboratively to provide comprehensive, holistic care.
Industry leadership
Through partnerships with training and research organizations, health system operations, national associations, and ethics committees, we maintain our leadership role in advancing psychedelic-assisted therapy.
Seamless integration
Our team’s extensive experience in public, community, and private healthcare ensures that your journey with us integrates smoothly with your existing healthcare services.
Experience the ATMA CENA advantage
At ATMA CENA, we believe everyone deserves access to impactful mental healthcare. Our unique approach combines evidence-based treatments, personalized care, and interdisciplinary expertise to deliver unparalleled results.
By partnering with industry leaders and aligning with healthcare regulations, we ensure our services remain accessible, affordable, and at the forefront of psychedelic-assisted therapy.
Start your journey to healing and self-discovery with ATMA CENA, and experience how the profound impact of our client-centered approach, adherence to the evidence, and collaboration amongst experts shapes our approach to psychedelic-assisted therapy.
Our values
Accessibility
Making our therapies easily available to all is key to fostering widespread mental wellness within all communities and cities.
Safety
Safety is at the heart of what we do, ensuring a nurturing space for healing through carefully planned and compassionate practices.
Innovation
Embracing innovation with care, we welcome learning about new treatments and approaches to enhance healing and well-being.
Collaboration
Collaboration is about coming together, sharing knowledge and warmth to make the healing process more enriching for everyone involved.
Integrity
With integrity, we act with honesty and transparency, fostering trust within our community, with every step taken in sincerity.
Our story
The first encounter between Reverdi Darda, CEO of Cena Life, and Vu Tran, CEO of ATMA Journey, was a serendipitous meeting at the MAPS conference in Denver in 2023. This initial introduction marked the beginning of an inspiring collaboration. The conference was a powerful catalyst, sparking discussions about the potential to merge their insights and propel the industry forward through a unified approach.
Upon returning to Alberta—Reverdi to Edmonton and Vu to Calgary—the dialogue continued, focusing on a joint venture centred around Canada’s Special Access Program (SAP). They passionately deliberated on how to enhance access to psychedelics through this program, addressing critical challenges such as the need for secure and compliant delivery settings for MDMA and psilocybin therapy. Recognizing that existing environments were often informal spaces such as people’s basements, they envisioned establishing clinics that met Alberta’s recently put out (2022) psychedelic-assisted tehrapy guidelines. This initiative aimed to foster confidence among doctors and physicians in prescribing SAP therapies to their patients.
Driven by a shared vision of accessibility, Reverdi and Vu saw the necessity of laying the groundwork for regular psychedelic therapy, extending beyond SAP. They realized that building the required infrastructure now, would ensure its readiness by the time MDMA and psilocybin gained legal status. This foresight and commitment to creating a safe, accessible, and regulated environment for psychedelic therapy underscore the foundation of ATMA CENA’s mission.
Meet the leadership team
Reverdi Darda
Chief Executive Officer and Co-Founder
Vu Tran
Chief Business Development Officer and Co-Founder
Najla Guthrie
Chief Investment Officer and Co-Founder
Juan Tellez
Vice President of Corporate Services
Jacque Lovely
Vice President of Western Operations and Chief Operating Officer
Andrew Charrette
Vice President of Eastern Operations
